Publications
5674 Results
- Journal / Conference
- Blood 122(20):3432-3439;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID24092933
- PMC
- PMC3829116
- Study Number(s)
- S0703
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
- Journal / Conference
- American Journal of Epidemiology 178(5):741-751;
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID23813705
- PMC
- PMC3755644
- Study Number(s)
- SWOG-9217
Should modest elevations in prostate specific antigen or international prostate symptom score, or their rates of increase over time, be used as surrogate measures of incident benign prostatic hyperplasia?
- Journal / Conference
- San Antonio Breast Cancer Symposium, abstr. OT3-3-02; poster presentation;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0812
Phase IIB randomized double-blind placebo-controlled biomarker modulation study of high dose vitamin D in premenopausal women at high-risk for breast cancer: SWOG S0812
- Journal / Conference
- San Antonio Breast Cancer Symposium, abst. S5-07; oral presentation;
- Year
- 2013
- Research Committee(s)
- Breast
- Study Number(s)
- S0500
SWOG S0500 - a randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment
- Journal / Conference
- San Antonio Breast Cancer Symposium, abst S1-07; oral presentation;
- Year
- 2013
- Research Committee(s)
- Breast
- Study Number(s)
- E1199, E2197
Prognostic value of tumor-infiltrating lympocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
- Journal / Conference
- Haematologica 98(supplement 2):P010;CS, p.4; International Symposium on Hodgkin Lymphoma (Oct.12-15, 2013, Cologne, Germany), poster presenttion;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496
Prospective evaluation of the utility of the international prognostic score (IPS) for patients with advanced hodgkin lymphoma (HL) treated with contemporary therapy: results from US intergroup trial E2496
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 8592); ASCO Annual Meeting
- Year
- 2013
- Research Committee(s)
- Myeloma
Strategies to overcome barriers to accrual (BtA) to NCI-sponsored clinical trials: a project ofthe NCI-Myeloma Steering Committee Accrual Working Group (NCI-MYSC AWG)
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 520)
- Year
- 2013
- Research Committee(s)
- Breast
- Study Number(s)
- N9831
The relationship between quantitative HER2 gene expression by the 21-gene RT-PCR assay and adjuvant trastuzumab (H) benefit in NCCTG (Alliance) N9831
- Journal / Conference
- Journal of Clinical Oncology 31(suppl;abstr 7510)
- Year
- 2013
- Research Committee(s)
- Lung
Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): an Alliance-led analysis
- Journal / Conference
- International Cancer Control Congress (Nov. 3-6, 2013, Lima, Peru), oral;
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S1119